FDA Approves New Waived Tests Under CLIA
- By admin aapc
- In Billing
- July 1, 2011
- Comments Off on FDA Approves New Waived Tests Under CLIA
The Centers for Medicare & Medicaid Services (CMS) released, June 17, the latest laboratory tests approved by the Food and Drug Administration (FDA) as waived tests under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). According to CMS Transmittal 2244, there will be five new tests that are covered under Medicare Parts A and B effective Oct. 1, 2011.
Listed below are the latest FDA-approved waived tests:
Code | Effective Date | Description |
87880QW | Feb. 2, 2011 | BTNX Rapid Response Strep A Rapid Test Strips |
82274QW G0328QW |
March 24, 2011 | OC-Light iFOB Test |
G0434QW | April 1, 2011 | CLIA-waived, Inc. Rapid Drug Test Cup{OTC} |
G0434QW | April 1, 2011 | Instant Technologies, iCup DX Drug Screen Cup |
86318QW | April 7, 2011 | Stanbio Rely H. plyori Rapid Test (Whole Blood) (Finger-stick only) |
Note that drug tests reported with HCPCS Level II code G0434QW or CPT® code 82055QW, and the screening test to measure sperm concentration (reported with CPT® code 89300QW), may not be covered in all instances. Contact your Medicare carrier for claims instructions.
With the exception of CPT® codes 81002, 81025, 82270, 82272, 82962, 83026, 84830, 85013, and 85651, tests must have the modifier QW to be recognized as a waived test.
- Gain an Edge By Using eBooks - October 3, 2023
- Healthcare in Australia - September 1, 2023
- Get Ready for CMS-HCC V28 - June 30, 2023
Anyone knows the cpt code for rh blood typing using an Eldoncard in the office?